Once Versus Twice Bisoprolol Dosage Regimen in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft Surgery
Coronary Artery Bypass Grafting, Postoperative Atrial Fibrillation, Coronary Artery Disease
About this trial
This is an interventional prevention trial for Coronary Artery Bypass Grafting focused on measuring Bisoprolol, Dosage regimens, heart rate, blood pressure
Eligibility Criteria
Inclusion Criteria: Adult patients: 18 to 65 years old Diagnosed with coronary heart disease or myocardial infarction and scheduled for coronary artery bypass surgery Exclusion Criteria: History of Ventricular arrhythmia, atrial fibrillation, atrial flutter, left bundle block, AV block grade II/III History of Sick sinus syndrome, sinoatrial heart block History of valve replacement Permanent Pacemaker LVEF less than 30% Unstable Heart failure Cardiogenic shock Sustained systolic blood pressure less than 100 mmHg or HR less than 50 bpm at recruitment Severe chronic obstructive airway disease Severe asthma unless was on previously tolerated bisoprolol dose Uncontrolled diabetes mellitus unless was on previously tolerated bisoprolol dose Pregnant/Lactation Previous recent stroke Creatinine clearance less than 30 ml/min End stage liver disease (liver cirrhosis) Drug dependance history Untreated phaeochromocytoma Vasospastic angina Thyrotoxicosis History of advanced staged of peripheral vascular disease Hypersensitivity Patients on any other beta-blocker other than bisoprolol Patients on bisoprolol higher than 5 mg/day.
Sites / Locations
- El-Demerdash Cardiac Academy HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Once Daily Regimen
Twice Daily Regimen
Patients who take bisoprolol 5 mg per day.
Patients who take bisoprolol 2.5 mg twice per day.